Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Ibuprofen by PLx Pharma Winddown for Inflammation: Likelihood of Approval
Ibuprofen is under clinical development by PLx Pharma Winddown and currently in Phase II for Inflammation. According to GlobalData, Phase...